Background and Design: Erythroderma may be the result of many differen
t causes. There are several publications on this subject, most of them
from England, the United States, and the Scandinavian countries repor
ting a different incidence of each etiologic group. Our objective has
been to determine the frequency of erythroderma in. our environment, i
ts cause, and patient evolution. We reviewed the clinical, laboratory,
and biopsy material of 56 patients diagnosed with erythroderma who we
re treated in our department in the last 8 years (1984 through 1991).
Patients were followed up to know the evolution of the erythroderma. R
esults: The male-female ratio was 4:1. The mean age at diagnosis was 5
7 years. Dermatoses were the most frequent cause of erythroderma (62.5
%), followed by topical or systemic drug reactions (16%), and cutaneou
s T-cell lymphomas (12.5%). Follow-up information was obtained from 42
patients (66%). Eight patients died (19%), but only in three cases wa
s death directly related to erythroderma (7.14%). The group associated
with the best prognosis was that related to drugs. The best clinicohi
stologic correlation was found in cutaneous T-cell lymphoma-related er
ythroderma. Conclusions: Erythroderma of unknown cause and protracted
course may be secondary to senile atopic dermatitis, intake of drugs o
verlooked by the patients, and patients who are in slow progression to
cutaneous T-cell lymphoma. Close follow-up of erythrodermas of unknow
n cause by repeating cutaneous biopsies will in time allow an early di
agnosis in patients in the latter group.